FY2012 Sales Up 18% for Both Generic-Only Makers, Research-Driven Pharmas’ Generic Units; Govt Incentive Measures Biggest Contributor

Combined sales of the top three generic-only makers and combined sales of the generic units (operations) of 11 research-oriented companies and one pharmacy chain operator each leapt 18.3% in FY2012 over the previous year, according to their earnings reports and...read more